Ironwood Pharmaceuticals | IRWD - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Almirall EUR 531.16M 13.76M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 133.3M 6.04M 2026-06
Astellas Pharma JPY 497.36B 41.8B 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Charles River Laboratories USD 3.23B 387.38M 2026-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Halozyme Therapeutics USD 198M 4.66M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
MacroGenics USD 42.87M 21.68M 2026-06
Moderna USD 1.18B 223M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
Pacira USD 1.18B 995.96M 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Takeda JPY 981.78B 36.71B 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12